{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:38Z","timestamp":1792823978294,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD23\/00173"],"award-info":[{"award-number":["CD23\/00173"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP22\/00106"],"award-info":[{"award-number":["CP22\/00106"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00465"],"award-info":[{"award-number":["PI24\/00465"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01253"],"award-info":[{"award-number":["PI22\/01253"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021. 01773.CEECIND"],"award-info":[{"award-number":["2021. 01773.CEECIND"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-ONC\/4165\/2021"],"award-info":[{"award-number":["PTDC\/MED-ONC\/4165\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["COMPETE2030-FEDER-00707100-15942"],"award-info":[{"award-number":["COMPETE2030-FEDER-00707100-15942"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030406","name":"Peoria County Bar Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101105382"],"award-info":[{"award-number":["101105382"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["GAIN IN607D-2023\/09"],"award-info":[{"award-number":["GAIN IN607D-2023\/09"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["24-0390"],"award-info":[{"award-number":["24-0390"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007320","name":"Albert Einstein Cancer Center","doi-asserted-by":"publisher","award":["AECC predoctoral grant 2025"],"award-info":[{"award-number":["AECC predoctoral grant 2025"]}],"id":[{"id":"10.13039\/100007320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218893","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:43:59Z","timestamp":1791848639000},"page":"218893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models"],"prefix":"10.1016","volume":"661","author":[{"given":"Cl\u00e9ment","family":"Anfray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1622-3068","authenticated-orcid":false,"given":"Alba","family":"Pensado-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-2806","authenticated-orcid":false,"given":"Fl\u00e1via","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailenis","family":"Rosales S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Sandino Somoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-0338","authenticated-orcid":false,"given":"Aldo","family":"Ummarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Ander","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Toutain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-0270","authenticated-orcid":false,"given":"Samuel","family":"Valable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Garc\u00eda Campelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Allavena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9235-1278","authenticated-orcid":false,"given":"Fernando","family":"Torres And\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218893_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008799","article-title":"Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy","volume":"12","author":"Jeon","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41698-023-00364-1","article-title":"Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer","volume":"7","author":"Rolfo","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218893_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003065","article-title":"T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells","volume":"9","author":"Nouri","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010950","article-title":"Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers","volume":"13","author":"Sacristan Santos","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004784","article-title":"Toll-like receptor 7\/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer","volume":"10","author":"Ye","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002408","article-title":"Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity","volume":"9","author":"Anfray","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib7","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/biomedicines10071590","article-title":"Innate and adaptive responses of intratumoral immunotherapy with endosomal toll-like receptor agonists","volume":"10","author":"And\u00f3n","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2026.218893_bib8","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/pharmaceutics14112285","article-title":"Immunotherapeutic implications of Toll-like receptors activation in tumor microenvironment","volume":"14","author":"Zheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2026.218893_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011173","article-title":"Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer","volume":"13","author":"Adams","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2395067","article-title":"Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade","volume":"13","author":"Rwandamuriye","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2026.218893_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217410","article-title":"STING in cancer immunoediting: modeling tumor-immune dynamics throughout cancer development","volume":"612","author":"Zhang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218893_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s43018-024-00889-9","article-title":"Systemic IFN-I combined with topical TLR7\/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells","volume":"6","author":"Sanlorenzo","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218893_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218893_bib14","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3390\/cancers12123585","article-title":"Angiopoietin-2 combined with radiochemotherapy impedes glioblastoma recurrence by acting in an autocrine and paracrine manner: a preclinical study","volume":"12","author":"Helaine","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218893_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-0716-2914-7_7","article-title":"In vivo analysis of tumor-associated macrophages in the tumor microenvironment","volume":"2614","author":"Anfray","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2026.218893_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1758834017749748","article-title":"Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients","volume":"10","author":"Karachaliou","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.canlet.2026.218893_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jconrel.2025.01.042","article-title":"Chitosan\/\u03b3-PGA nanoparticles and IFN-\u03b3 immunotherapy: a dual approach for triple-negative breast cancer treatment","volume":"379","author":"Castro","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.canlet.2026.218893_bib18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/2211-5463.70052","article-title":"Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies","volume":"15","author":"Kalni\u0146a","year":"2025","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.canlet.2026.218893_bib19","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1084\/jem.20180534","article-title":"Macrophages of distinct origins contribute to tumor development in the lung","volume":"215","author":"Loyher","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218893_bib20","doi-asserted-by":"crossref","DOI":"10.3791\/68505","article-title":"In vivo glioblastoma tumor modeling via stereotaxic injection in mice for tumor progression studies","author":"Silva-Ag\u00fcero","year":"2025","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.canlet.2026.218893_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1402578","article-title":"In vivo characterization of brain tumor biomechanics: magnetic resonance elastography in intracranial B16 melanoma and GL261 glioma mouse models","volume":"14","author":"Janas","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218893_bib22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41591-025-03636-4","article-title":"Reprogramming the tumor immune microenvironment to treat glioblastoma","volume":"31","author":"Joyce","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.canlet.2026.218893_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110810","article-title":"Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment","volume":"27","author":"Lim","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218893_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.canlet.2026.218893_bib25","first-page":"110","article-title":"Immunocytokines and cytokine neutralization for cancer immunotherapy","volume":"S2405\u20138033","author":"Berraondo","year":"2025","journal-title":"Trends Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:23:01Z","timestamp":1792822981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"alternative-id":["S0304383526006579"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218893","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218893"}}